Aspartate aminotransferase-to-platelet ratio predicts response to transarterial chemoembolisation and prognosis in hepatocellular carcinoma patients

To evaluate the value of the aspartate aminotransferase-to-platelet ratio index (APRI) for hepatocellular carcinoma (HCC) patients who underwent transarterial chemoembolisation (TACE). A total of 315 patients were enrolled, who were randomly divided into the training cohort (n=158) and the validatio...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical radiology 2018-03, Vol.73 (3), p.259-265
Hauptverfasser:	Tang, T., Qiu, J.-L., Li, G.-W., Huang, M.-P., Li, Y., Li, Y.-J., Gu, S.-Z.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Alanine Transaminase - blood Antineoplastic Agents - administration & dosage Aspartate Aminotransferases - blood Biomarkers, Tumor - blood Carcinoma, Hepatocellular - blood Carcinoma, Hepatocellular - diagnostic imaging Carcinoma, Hepatocellular - therapy Chemoembolization, Therapeutic - methods Ethiodized Oil - administration & dosage Female Fluoroscopy Humans Liver Neoplasms - blood Liver Neoplasms - diagnostic imaging Liver Neoplasms - therapy Male Middle Aged Platelet Count Predictive Value of Tests Prognosis Software Survival Analysis Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!